Amgen Inc (NASDAQ: AMGN)
DRUGS - BiotechnologySector: Health Care
Stock price data as of 11/15/2019
Closing price: 220.86
| Support price level: | $202.21 |
| Resistance price level: | N/A |
| Relative strength index (14-day RSI) | 77.0 |
| Beta | 0.75 |
- AMGN is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- Volatility is forecast to fall over the next month.
- With RSI > 70, AMGN is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
| Low | High | Price as % of Range |
| $166.70 | $221.31 | 99.3% |
| 200 day | 50 day | 20 day | 10 day |
| $189.62 | $203.47 | $212.96 | $218.60 |
| Historical (5 year) |
Last month | Current estimate | Next month forecast |
| 23.7% | 18.1% | 19.1% | 21.9% |
- 5.2% in the next week.
- 12.4% in the next month.
- 44.7% in the next year.
